Mubadala reported continued contributions to the UAE economy in 2025, supporting job creation, attracting investment, and advancing strategic industries across the nation.
The investment platform contributed Dhs45 billion to Abu Dhabi’s GDP, equivalent to 5.7% of the emirate’s non-oil GDP. It also supported around 98,000 jobs directly and indirectly, marking a 51% increase since 2021.
Aldar and Mubadala Capital launched Aldar Capital, a platform connecting global investors with real asset opportunities in the GCC. Headquartered in the Abu Dhabi Global Market, the platform’s first fund aims to raise US$1 billion (Dhs3.7 billion) in 2026.
Mubadala Bio, a new national life sciences initiative, began local manufacturing of eight essential medicines and plans to operate 10 global facilities to strengthen UAE biopharma capabilities.
M42, in partnership with Oracle Health, launched a program to unify patient records across the UAE, integrating data from the Emirate Genome Program to support pharmacogenomic recommendations at the point of care.
Emirates Global Aluminium (EGA) advanced plans for a new primary aluminum plant in the US while developing next-generation smelting technology.
A major expansion of Abu Dhabi’s financial district on Al Maryah Island was announced in partnership with Aldar, valued at over Dhs60 billion.
Masdar began construction of the world’s largest renewable energy project, integrating solar power and battery storage to deliver 1 gigawatt (GW) of baseload renewable energy in partnership with Emirates Water and Electricity Company.
tanvir@dubainewsweek.com
